Emerging ethical perspectives in the CRISPR genome-editing debate

Personalized Medicine Perspective by Silvia Camporesi et al. (King’s College London, UK) providing an overview of the ethical issues in the international CRISPR genome editing debate from March 2015 to September 2016.

Thumb rme journal large
Nov 04, 2016

The clustered regularly interspaced short palindromic repeats (CRISPR) genome editing tool has been ubiquitously utilized in biology laboratories worldwide for a variety of purposes and routine genetic modifications: for example, the California the Institute for Regenerative Medicine (CIRM) announced that they will finance research on CRISPR on human embryos.

This Open Access perspective by Silvia Camporesi et al. from King’s College London (UK), published in Personalized Medicine, discusses experiments that have demonstrated the technical feasibility of cultivating embryos in vitro for up to 14 days and possibly beyond this limit, and the ethical issues arising from the proposal to extend the limit beyond 14 days.

Camporesi S, Cavaliere G. Emerging ethical perspectives in the clustered regularly interspaced short palindromic repeats genome-editing debate. Pers. Med.13(6), 575–586 (2016).

Author for correspondence: silvia.camporesi@kcl.ac.uk

Medium rme journal large


eCommunity, Future Science Group

RegMedNet is a networking site where users can share their knowledge and insights. This profile will share some content and updates from the RegMedNet team, including webinars, news and journal articles.


Thumb alex photo 2
Alexandra Thompson over 2 years ago

If you like this, you make also like Magda Papadaki's article from earlier this year https://www.regmednet.com/users/4897-magda-papadaki/posts/4588-crispr-taking-the-short-cut-to-a-healthy-genome-editing-enterprise